Target intelligence / Profile preview

Scavenger receptor on antigen-presenting cell (SR (used generically, but specific members like SR-A1, CD163, SCAR-F1 have unique abbreviations))

Target
SR (used generically, but specific members like SR-A1, CD163, SCAR-F1 have unique abbreviations)
Molecular classification
Receptor, Pattern recognition receptor (PRR), Cell-surface receptor, Membrane protein, Endocytic receptor
01

Overview

Scavenger receptors are a structurally diverse superfamily of cell-surface and endocytic receptors prominently expressed on antigen-presenting cells (such as macrophages, dendritic cells, and B cells) which recognize a wide spectrum of ligands including modified lipoproteins, pathogens, apoptotic cells, and endogenous biomolecules. Functioning as pattern recognition receptors, they play central roles in innate immunity through ligand binding, internalization, phagocytosis, and cooperation with other immune receptors like Toll-like receptors. They are implicated in the pathogenesis of infection, atherosclerosis, autoimmunity, and inflammation, and are emerging as candidate drug targets and disease biomarkers, but the family encompasses numerous distinct receptor proteins, each with unique attributes and disease associations.

Other names
Scavenger receptorSRscavenger receptor class A (SR-A)scavenger receptor class B (SR-B)scavenger receptor expressed by endothelial cells (SREC)CD163SR-A1SR-B1SCAR-F1MEGF10
02

Mechanism of action

Blockade or modulation of ligand binding to interfere with pathogen attachment/entry or inflammatory signaling Antibody-drug conjugates utilize receptor-mediated endocytosis for targeted drug delivery Use of soluble SR fragments or antagonists to neutralize pathogen-associated ligands or modulate immune responses

03

Biological functions

Innate immune responsePhagocytosis of pathogens and apoptotic cellsRecognition and clearance of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs)Antigen uptake and presentationRegulation of inflammationLipid uptake and metabolismCooperation with Toll-like receptors (TLRs) for immune recognition and signaling
04

Disease associations

Infection (host-pathogen defense for bacteria, viruses, fungi, parasites)Inflammation (chronic and acute)Atherosclerosis (foam cell formation and plaque development)Autoimmune diseasesNeurodegenerative diseasesCancer (tumor immunity and progression)Other (cardiovascular disease)
05

Safety considerations

Targeting scavenger receptors could disrupt physiological clearance of pathogens, apoptotic cells, or lipids, leading to increased risk of infection, impaired tissue homeostasis, or altered immune responsesOff-target effects due to broad expression and ligand promiscuity among family membersPotential for exacerbating or suppressing inflammation depending on disease context
06

Interacting drugs

None specific to the entire scavenger receptor family; individual members (e.g., CD163) have been studied as targets for antibody-drug conjugates, therapeutics, or imaging agents

1 more in the full profile.

07

Biomarkers

Soluble CD163 and fragments of other scavenger receptors have been explored as biomarkers for inflammatory, infectious, or autoimmune diseasesExpression levels of specific scavenger receptors on antigen-presenting cells can serve as a functional or prognostic marker in immunity or disease

Beyond the preview

Go deeper on Scavenger receptor on antigen-presenting cell (SR (used generically, but specific members like SR-A1, CD163, SCAR-F1 have unique abbreviations)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scavenger receptor on antigen-presenting cell (SR (used generically, but specific members like SR-A1, CD163, SCAR-F1 have unique abbreviations)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call